Slingshot members are tracking this event:
BLINCYTO (Blinatumomab) Improved Overall Survival In Patients With B-Cell Precursor Acute Lymphoblastic Leukemia
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Jun 10, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Blincyto, Blinatumomab, B-cell, Acute Lymphoblastic Leukemia, Phase 3 Tower Study